In patients with NAFLD and different stages of liver fibrosis, the frequency of peripheral blood Siglec-7+CD56dimNK cells was suppressed, whereas the frequency of dysfunctional Siglec-7−PD-1+CD57+CD56dimNK cells was increased [11]. This evidence concerns the gene B3GAT1 and metabolic dysfunction-associated steatotic liver disease.